The National Comprehensive Cancer Network guidelines for pediatric and adult acute lymphoblastic leukemia (ALL) provide recommendations on standard treatment approaches based on the current evidence.
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
Acute lymphoblastic leukemia (ALL) may be confused with different types of hematological conditions. Confusion of ALL diagnosis with acute myeloid leukemia (AML), hairy cell leukemia and malignant ...
An artificial intelligence (AI)-driven machine learning model was refined and validated internationally to accurately classify acute leukemia subtypes from routine laboratory data, according to Merlin ...
Unlock the potential for faster, more comprehensive leukemia characterization with this webinar from Dana-Farber Cancer Institute expert Salvatore Benfatto. Acute leukemia (AL) is an aggressive form ...
Researchers at Dana-Farber Cancer Institute have developed a diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided ...
Cancer drug revumenib passed a pivotal test of its efficacy in patients with a hard-to-treat form of leukemia, drugmaker Syndax Pharmaceuticals said Monday. The Phase 2 AUGMENT-101 trial met its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback